Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.26T | 2.06T | 1.71T | 1.02T | 728.68B |
Gross Profit | 418.31B | 413.67B | 281.80B | -54.47B | -298.29B |
EBITDA | 370.58B | 372.59B | 289.57B | 9.59B | -350.22B |
Net Income | 153.03B | 157.10B | 89.48B | -143.63B | -404.62B |
Balance Sheet | |||||
Total Assets | 3.62T | 3.57T | 3.37T | 3.22T | 3.21T |
Cash, Cash Equivalents and Short-Term Investments | 1.22T | 1.26T | 1.18T | 950.99B | 965.72B |
Total Debt | 1.35T | 1.48T | 1.61T | 1.75T | 1.66T |
Total Liabilities | 2.48T | 2.52T | 2.50T | 2.42T | 2.20T |
Stockholders Equity | 1.13T | 1.04T | 862.42B | 797.25B | 1.01T |
Cash Flow | |||||
Free Cash Flow | 117.10B | 180.15B | 332.93B | -209.78B | -427.15B |
Operating Cash Flow | 373.03B | 420.62B | 449.82B | -76.41B | -270.44B |
Investing Cash Flow | -343.66B | -399.52B | -202.03B | 230.02B | -595.44B |
Financing Cash Flow | -170.15B | -136.04B | -144.91B | 93.65B | 1.10T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $29.86B | 9.24 | 27.70% | ― | 4.23% | 13.13% | |
79 Outperform | $9.26B | 9.19 | 13.95% | 1.08% | 4.52% | -7.58% | |
79 Outperform | $36.75B | 8.17 | 30.07% | 1.06% | 3.01% | -0.90% | |
74 Outperform | $12.54B | 11.59 | 138.69% | 1.54% | 6.41% | 49.58% | |
66 Neutral | $20.81B | 43.36 | 5.63% | 1.97% | 3.26% | 27.77% | |
64 Neutral | $8.25B | 14.44 | -21.27% | ― | 1.92% | 36.07% | |
62 Neutral | C$6.64B | 7.81 | 3.45% | 2.76% | 6.50% | -23.02% |